Hemochromatosis gene (HFE) polymorphisms are not associated with peripheral arterial disease

Herwig Köppel; Peter Krippl; Robert Gasser; Thomas C. Wascher; Bernhard Paulweber; Ernst Pilger; Wilfried Renner

doi:10.1055/s-0037-1614267

Thrombosis and Haemostasis, Table of Contents

Thromb Haemost 2004; 91(06): 1258-1259
DOI: 10.1055/s-0037-1614267

Letters to the Editor

Schattauer GmbH

Hemochromatosis gene (HFE) polymorphisms are not associated with peripheral arterial disease

Authors

Herwig Köppel
Peter Krippl
Robert Gasser
Thomas C. Wascher
Bernhard Paulweber
Ernst Pilger
Wilfried Renner

Abstract

Full Text

References

References
1 Meyers DG. The iron hypothesis-does iron cause atherosclerosis?. Clin Cardiol 1996; (19) 925-9.
2 McCord JM. Effects of positive iron status at a cellular level. Nutr Rev 1996; (54) 85-8.
3 Corti MC, Gaziano M, Hennekens CH. Iron status and risk of cardiovascular disease. Ann Epidemiol 1997; (07) 62-8.
4 Datz C, Haas T, Rinner H. et al. Heterozygosity for the C282Y mutation in the hemochromatosis gene is associated with increased serum iron, transferrin saturation, and hemoglobin in young women: a protective role against iron deficiency?. Clin Chem 1998; 44: 2429-32.
5 Gaenzer H, Marschang P, Sturm W. et al. Association between increased iron stores and impaired endothelial function in patients with hereditary hemochromatosis. J Am Coll Cardiol 2002; 40 (12) 2189-94.
6 Lekakis J, Papamicheal C, Stamatelopoulos K. et al. Hemochromatosis associated with endothelial dysfunction: evidence for the role of iron stores in early atherogenesis. Vase Med 1999; 04 (03) 147-8.
7 Salonen JT, Nyyssonen K, Korpela H. et al. High stored iron levels are associated with excess risk of myocardial infarction in eastern Finnish men. Circulation 1992; 86: 803-11.
8 Salonen JT, Nyyssonen K, Salonen R. Body iron stores and the risk of coronary heart disease. N Engl J Med 1994; 331: 1159.
9 Roest M, van der Schouw YT, de Valk B. et al. Heteroziguosity for a hereditary hemochromatosis gene is associated with cardiovascular death in women. Circulation 1999; 100: 1268-73.
10 Rasmussen ML, Folsom AR, Catellier DJ. et al. A prospective study of coronary heart disease and the hemochromatosis gene (HFE) C282Y mutation: the Atherosclerotic Risk in Communities (ARIC) study. Atherosclerosis 2001; 154 (03) 739-46.
11 Renner W, Pabst E, Paulweber B. et al. The angiotensin-converting-enzyme insertion/deletion polymorphism is not a risk factor for arterial disease. Atherosclerosis 2002; 165 (01) 175-8.
12 Sanchez LA, Veith FJ. Diagnosis and treatment of chronic lower extremity ischemia. Vase Med 1998; (03) 291-9.